MétaCan
Menu
Back to cohort
Record W4414873918 · doi:10.1093/brain/awaf375

Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers

2025· article· en· W4414873918 on OpenAlexafffund
Linda Karlsson, Shorena Janelidze, Nicolas R Barthélemy, Kanta Horie, Joseph Therriault, Lorenzo Gaetani, Giovanni Bellomo, Suzanne E. Schindler, Jacob W. Vogel, Ida Arvidsson, Kalle Åström, Brian A. Gordon, Cyrus A. Raji, Tammie L.S. Benzinger, Johanna Nilsson, Ann Brinkmalm, Sebastian Palmqvist, Erik Stomrud, Gemma Salvadó, Alexa Pichet Binette, Massimiliano Di Filippo, Lucilla Parnetti, Pedro Rosa‐Neto, Kaj Blennow, Randall J. Bateman, Niklas Mattsson, Oskar Hansson

Bibliographic record

VenueBrain · 2025
Typearticle
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsCentre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-MontréalUniversité de MontréalCentres Intégré Universitaires de Santé et de Services SociauxInstitut Universitaire de Gériatrie de MontréalMontreal Neurological Institute and Hospital
FundersNational Institute on AgingFonds de Recherche du Québec - SantéCharles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St. LouisAvid RadiopharmaceuticalsGenentechParkinsonfondenFondation pour la Recherche sur AlzheimerJulius ClinicalSkånes universitetssjukhusNovo NordiskKnut och Alice Wallenbergs StiftelseVetenskapsrådetEisaiEU Joint Programme – Neurodegenerative Disease ResearchHjärnfondenEuropean CommissionFondation Brain CanadaGHR FoundationAlzheimerfondenAlzheimer's Drug Discovery FoundationWeston Brain InstituteScience for Life LaboratoryCerveau TechnologiesCure Alzheimer's FundTeva Pharmaceutical IndustriesLife Sciences, University of California, Los AngelesBiogenEli Lilly and CompanyConsortium canadien en neurodégénérescence associée au vieillissementBristol-Myers SquibbLunds UniversitetSiemens HealthineersAmgenCanadian Institutes of Health ResearchFoundation for Barnes-Jewish HospitalProthenaAlexion PharmaceuticalsKonung Gustaf V:s och Drottning Victorias FrimurarestiftelseParkinson's FoundationSwedish Brain PowerSanofiNational Institutes of HealthMylanAlzheimer's Association
KeywordsBiomarkerCerebrospinal fluidConcordanceMultiple sclerosisProspective cohort studyDementiaNormalization (sociology)

Abstract

fetched live from OpenAlex

Concentration-based fluid biomarkers represent an informative and cost-effective way to detect and monitor Alzheimer's disease (AD) pathology. However, non-AD-related interindividual variation in biofluids can also affect biomarker concentrations. Here, we investigated whether normalization of CSF and plasma biomarkers to reference proteins, such as amyloid-β40 (Aβ40) and non-phosphorylated mid-region tau (np-tau), improves their robustness and reliability of representing AD pathology load. Using the Swedish BioFINDER-2 cohort [n = 1702, 50.7% male, mean (standard deviation) age 68.4 (12.2) years], we compared the associations between tau/Aβ-PET load and fluid biomarkers alone versus biomarkers in a ratio with a reference protein (Aβ40 or np-tau) in univariate linear regression models. Fluid biomarkers included CSF and plasma measures of p-tau217, p-tau181, p-tau205, np-tau181-190, np-tau195-210, np-tau212-221, Aβ42 and Aβ40; CSF MTBR-tau243, SNAP-25, neurogranin, YKL-40 and sTREM2; and plasma eMTBR-tau243. Biomarkers were measured with mass spectrometry assays and/or immunoassays. In addition, we performed validation and extended analyses, comparing, for example, group-level diagnostic differences and longitudinal biomarker trajectories, in three independent prospective cohorts [BioFINDER-1, Knight Alzheimer Disease Research Center (ADRC) and Translational Biomarkers in Aging and Dementia (TRIAD)] and in an Italian multiple sclerosis cohort. CSF Aβ40 normalization significantly strengthened the associations of several core CSF AD biomarkers, including CSF MTBR-tau243, p-tau isoforms and synaptic biomarkers, with tau-PET (ΔR2 = 0.064-0.24) and Aβ-PET (ΔR2 = 0.016-0.28). Normalization to CSF np-tau mainly improved concordance with Aβ-PET (ΔR2 = -0.0059 to 0.19). The strongest association with tau-PET was observed for MTBR-tau243/Aβ40 (R2 = 0.78, compared with 0.65 for non-normalized MTBR-tau243), and with Aβ-PET for p-tau217/np-tau (R2 = 0.65, compared with 0.46 for non-normalized p-tau217). Plasma biomarker associations with tau-PET improved when using normalization to plasma Aβ40 or np-tau (ΔR2 = 0.004-0.14), with the strongest effect for eMTBR-tau243/np-tau (R2 = 0.72 versus 0.60). Associations with Aβ-PET were enhanced with np-tau normalization (ΔR2 = 0.018-0.16, strongest for p-tau217/np-tau: R2 = 0.62 versus 0.53). The results were replicated in Knight ADRC and TRIAD. Furthermore, longitudinal analyses showed that Aβ40 normalization typically reduced interindividual rather than intra-individual variability over time. Normalization did not enhance group-level differences in inflammatory CSF biomarkers in AD, nor did it improve biomarker associations in the multiple sclerosis cohort. In conclusion, normalization of CSF and plasma biomarkers to reference proteins, such as Aβ40 or np-tau, enhances their association with brain tau and Aβ pathology, making already high-performing AD fluid biomarkers even more accurate.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.010
metaresearch head score (Gemma)0.019
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.010
Threshold uncertainty score0.053

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0100.019
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0020.002
Science and technology studies0.0010.001
Scholarly communication0.0020.001
Open science0.0010.002
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.043
GPT teacher head0.351
Teacher spread0.309 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueBrainSame topicDementia and Cognitive Impairment ResearchFrench-language works237,207